Taylor A. Harmon

ORCID: 0000-0003-0465-2316
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pain Mechanisms and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Erythrocyte Function and Pathophysiology
  • Mass Spectrometry Techniques and Applications
  • Pharmaceutical Economics and Policy
  • Adenosine and Purinergic Signaling
  • Advanced Proteomics Techniques and Applications
  • Pharmaceutical studies and practices
  • Sphingolipid Metabolism and Signaling

University of Florida
2020-2022

Different software and algorithms are available for peak picking in nontargeted metabolomics each may have its own strengths limitations. The choice of pick method can significantly influ-ence the results obtained, including number identity metabolites detected, their quantification, subsequent biomarker analysis. impact by different tools an untargeted metabolomics-based study is largely understated. This compares two popular open-source cancer cells, tissues, bio-fluids: XCMS MZmine 2....

10.1101/2025.03.04.641559 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-03-10

Spectrometric methods with rapid biomarker detection capacity through untargeted metabolomics are becoming essential in the clinical cancer research. Liquid chromatography-mass spectrometry (LC-MS) is a rapidly developing metabolomic-based technique due to its high sensitivity, reproducibility, and separation efficiency. However, translation diagnostics often limited long data acquisition times (∼20 min/sample) laborious sample extraction procedures when employed for large-scale studies....

10.1021/acs.jproteome.0c00006 article EN Journal of Proteome Research 2020-03-27

Abstract Emerging evidence implicates the sphingosine-1-phosphate (S1P) receptor subtype 1 (S1PR1) in development of neuropathic pain. Continued investigation signaling pathways downstream S1PR1 are needed to support antagonists. In rodents, intrathecal (i.th.) injection SEW2871, a selective agonist, activates nod-like family, pyrin domain containing 3 (NLRP3) inflammasome, increases interleukin-1β (IL-1β) and causes behavioral hypersensitivity. I.th. IL-1β antagonist blocks SEW2871-induced...

10.21203/rs.3.rs-852148/v1 preprint EN cc-by Research Square (Research Square) 2021-09-21
Coming Soon ...